Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02440711 · ClinicalTrials.gov registry record · NA

Evaluation of a Modified Running-specific Prosthetic Foot

A NA study of Transtibial Amputation, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT02440711: Completed NA study of Transtibial Amputation, sponsored by University of Washington.

NCT02440711 is a NA study of Transtibial Amputation that has completed, run by University of Washington. The registered enrollment target is 36 participants, above the 28-participant average among 4 other Transtibial Amputation trials with a reported enrollment target (29% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02440711, a NA study of Transtibial Amputation, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to evaluate endurance, walking performance, mobility, and perceived exertion of transtibial prosthesis users (i.e., study participants) walking with a conventional energy storing prosthetic foot (ESF) and a novel modified running-specific prosthesis (mRSF). A randomized cross-over study will be conducted to determine if the mRSF provides superior performance to the ESF, which is commonly prescribed to most active individuals with lower limb amputation.

Primary Outcome

Breath-by-Breath VO2 was collected as participants walked on a treadmill at self selected fast, normal, and slow speeds. Participants walked for 6 minutes at each speed (and in each experimental condition). VO2 was normalized energy expenditure to each participant's biological mass (i.e., body mass without prosthesis) Normalized VO2 data were averaged to produce 30-s values for minutes 3-6 of each trial. These 30-s values were used in for the described analyses. Both gross and net VO2 were exami

Conditions Studied

Interventions

  • DEVICE Energy storing foot (ESF)
  • DEVICE Modified running specific foot (mRSF)

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2015-05
Est. Completion 2018-03
Phase NA
University of Washington

1,048 total trials

What the finished NCT02440711 record still lists

NCT02440711 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, above the 28-participant average among 4 other Transtibial Amputation trials with a reported enrollment target (29% higher).

The record links to 1 condition, with Transtibial Amputation appearing as the primary indexed condition, and to 2 interventions - of which Energy storing foot (ESF) is the first listed.

NCT02440711 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT02440711 about?

NCT02440711 is a clinical study titled "Evaluation of a Modified Running-specific Prosthetic Foot". The goal of this study is to evaluate endurance, walking performance, mobility, and perceived exertion of transtibial prosthesis users (i.e., study participants) walking with a conventional energy storing prosthetic foot (ESF) and a novel modified running-specific prosthesis (mRSF). A randomized cro...

What is the current status of trial NCT02440711?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2015-05. Estimated completion is 2018-03.

What conditions does trial NCT02440711 study?

This clinical trial studies the following conditions: Transtibial Amputation.

What interventions are being tested in trial NCT02440711?

The interventions under investigation include: Energy storing foot (ESF) (DEVICE), Modified running specific foot (mRSF) (DEVICE).

Who is sponsoring clinical trial NCT02440711?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02440711 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Transtibial Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02440711, the US trial registry maintained by the National Library of Medicine. NCT02440711 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.